Cargando…

The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy

Recent data supports a potentially significant role for immune checkpoint inhibitors in the treatment of gastric cancer. However, there are few data on the clinical implications of immunotherapy markers in gastric signet-ring cell carcinoma (SRCC). We evaluated the expression of programmed cell deat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Shenying, Xu, Bo, Yu, Lixia, Fu, Yao, Wu, Hongyan, Fan, Xiangshan, Wei, Jia, Liu, Baorui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503577/ https://www.ncbi.nlm.nih.gov/pubmed/28418918 http://dx.doi.org/10.18632/oncotarget.16407

Ejemplares similares

Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma
por: Ding, Naiqing, et al.
Publicado: (2023)

TAZ Is Highly Expressed in Gastric Signet Ring Cell Carcinoma
por: Yue, Guofeng, et al.
Publicado: (2014)

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
por: Ding, Naiqing, et al.
Publicado: (2019)

Immunohistochemical analysis of PD-L1 and tumor-infiltrating immune cells expression in the tumor microenvironment of primary signet ring cell carcinoma of the prostate
por: Teng, Qi-Liang, et al.
Publicado: (2022)

Circulating memory PD-1(+)CD8(+) T cells and PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
por: Liu, Jiang, et al.
Publicado: (2023)

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
por: Bevins, Nicholas J., et al.
Publicado: (2022)

Comprehensive Analysis of Clinicopathological and Molecular Features to Predict Anti-PD-1-Based Therapy Efficacy in Patients with Advanced Gastric Signet Ring Cell Carcinoma
por: Hu, Yan, et al.
Publicado: (2023)

Gastric metastasis of mammary signet ring cell carcinoma--a differential diagnosis with primary gastric signet ring cell carcinoma.
por: Yim, H., et al.
Publicado: (1997)

Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study
por: Shi, Tao, et al.
Publicado: (2019)

Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
por: Escors, David, et al.
Publicado: (2022)

PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer
por: Shen, Yang, et al.
Publicado: (2020)

Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge
por: Akouh, Nada, et al.
Publicado: (2023)

PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells
por: Balança, Camille-Charlotte, et al.
Publicado: (2021)

Bladder metastasis of gastric signet-ring cell carcinoma
por: Kazaz, İlke Onur, et al.
Publicado: (2018)

Difference Between Signet Ring Cell Gastric Cancers and Non-Signet Ring Cell Gastric Cancers: A Systematic Review and Meta-Analysis
por: Zhang, Chi, et al.
Publicado: (2021)

Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival
por: Liu, Jingwei, et al.
Publicado: (2020)

Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups
por: Tomassen, T., et al.
Publicado: (2022)

Massive gastric distension due to signet-ring cell gastric adenocarcinoma
por: Zakaria, Ali, et al.
Publicado: (2020)

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer
por: Xu, Bo, et al.
Publicado: (2022)

Breast Metastatic Localization of Signet-Ring Cell Gastric Carcinoma
por: Parrell Soler, C., et al.
Publicado: (2011)

Pericardial Biopsy Revealed Gastric Signet-Ring Cell Cancer
por: Hashimoto, Yu, et al.
Publicado: (2015)

Signet ring cells in carcinomatous lymphangitis due to gastric adenocarcinoma()()
por: Souza, Beatriz da Silva, et al.
Publicado: (2020)

A Case of Gastric Amphicrine Signet-Ring Cell Carcinoma
por: Hanamatsu, Yuki, et al.
Publicado: (2019)

Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma
por: Tian, Hua-Kai, et al.
Publicado: (2022)

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy
por: Kortekaas, Kim E, et al.
Publicado: (2021)

PD-1, but Not PD-L1, Expressed by Islet-Reactive CD4(+) T Cells Suppresses Infiltration of the Pancreas During Type 1 Diabetes
por: Pauken, Kristen E., et al.
Publicado: (2013)

The enigma of signet ring cells
por: Sharma, Gitika, et al.
Publicado: (2020)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

PD-L1 Expression and CD8(+) T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer
por: Wang, Yangyang, et al.
Publicado: (2018)

SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancers
por: Zhang, Qun, et al.
Publicado: (2021)

Systemic CD4 immunity: A powerful clinical biomarker for PD‐L1/PD‐1 immunotherapy
por: Zuazo, Miren, et al.
Publicado: (2020)

Systemic Anti–PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
por: Portnow, Jana, et al.
Publicado: (2020)

PD-1(+) mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
por: Li, Jun, et al.
Publicado: (2022)

Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients
por: Wei, Jia, et al.
Publicado: (2021)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
por: Däster, Silvio, et al.
Publicado: (2020)

Metastatic Signet-Ring Cell Gastric Carcinoma Masquerading as Breast Primary
por: Doval, Dinesh Chandra, et al.
Publicado: (2009)

Metastatic Gastric Signet Ring Cell Carcinoma Mimicking Crohn's Disease
por: Winter, Michael W., et al.
Publicado: (2018)

Metastatic Gastric Signet Ring Cell Adenocarcinoma Presenting With Colonic Stenosis
por: Hanzel, Jurij, et al.
Publicado: (2020)

Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges
por: Li, Yang, et al.
Publicado: (2020)

Clinicopathological Evaluation of Gastric Signet Ring Cell Carcinoma: Our Experience
por: Altay, Sevgi B, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fu3211u1n2e654baiogo6d0t49